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Wehavepreviously shown that impulsivity in rats is linked todecreaseddopamineD2/3 receptor availability in the ventral striatum. In the
present study, we investigated, using longitudinal positron emission tomography (PET), the effects of orally administeredmethylpheni-
date (MPH), a first-line treatment for attention deficit hyperactivity disorder, on D2/3 receptor availability in the dorsal and ventral
striatum and related these changes to impulsivity. Rats were screened for impulsive behavior on a five-choice serial reaction time task.
After a baseline PET scan with the D2/3 ligand [
18F]fallypride, rats received 6 mg/kg MPH, orally, twice each day for 28 d. Rats were then
reassessed for impulsivity and underwent a second [18F]fallypride PET scan. Before MPH treatment, we found that D2/3 receptor avail-
ability was significantly decreased in the left but not the right ventral striatumof high-impulse (HI) rats comparedwith low-impulse (LI)
rats. MPH treatment increased impulsivity in LI rats, andmodulated impulsivity and D2/3 receptor availability in the dorsal and ventral
striatumofHI rats through inverse relationships with baseline levels of impulsivity andD2/3 receptor availability, respectively. However,
we found no relationship between the effects of MPH on impulsivity and D2/3 receptor availability in any of the striatal subregions
investigated. These findings indicate that trait-like impulsivity is associated with decreased D2/3 receptor availability in the left ventral
striatum, and that stimulant drugs modulate impulsivity and striatal D2/3 receptor availability through independent mechanisms.
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Introduction
Converging evidence from neuroimaging, clinical psychopharma-
cology, and animal models implicates dysregulated dopaminergic
and norepinephrinergic neurotransmission in the pathophysiology
of attention deficit hyperactivity disorder (ADHD), the prototyp-
ical impulse control disorder (Biederman, 2005; Arnsten, 2006;
Dalley et al., 2011). Methylphenidate (MPH), which acts by in-
creasing extrasynaptic dopamine (DA) and norepinephrine (NE)
levels by blocking their reuptake (Zetterstro¨m et al., 1988), has
been the first-line pharmaceutical therapy for ADHD (Wilens,
2008). Although its pharmacological action has been well char-
acterized, the precise neurobiological mechanisms underlying
the therapeutic effects of MPH remain unclear. Recent findings
suggest that only specific neurocognitive processes in domains
such as impulse control and attention are affected by MPH, and
that these interact with the drug in a baseline performance-
dependentmanner (Dews andWenger, 1977; Sahakian and Rob-
bins, 1977; Robbins and Sahakian, 1979; Turner et al., 2003;
Clatworthy et al., 2009; DeVito et al., 2009). Such effects, which
depend on optimizing catecholamine levels in the brain, are hy-
pothesized to follow an inverted U-shaped function (Clatworthy
et al., 2009; van der Schaaf et al., 2013).
Recently, we reported (Caprioli et al., 2013) a similar baseline-
dependent effect of cocaine in a preclinical animal model of im-
pulsivity. We reported that impaired response inhibition in a
rodent model of impulsivity is associated with a deficiency in DA
D2/3 receptor availability in the left ventral striatum, and that
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prior response-contingent exposure to cocaine both restored
D2/3 receptor availability in this region and improved impulse
control. This evidence directly supports the baseline dependency
hypothesis at the neurobiological level in the striatum, and this
may be relevant to recent findings (Volkow et al., 2007a,b, 2009,
2012). Indeed, a set of well powered case-control positron emission
tomography (PET) studies in adult medication-naive ADHD pa-
tients, found ADHD to be associated with reduced D2/3 receptor
availability in the nucleus accumbens and caudate (Volkow et al.,
2007a,b, 2009), and that treatment response was associated with
increased DA transmission in the ventral striatum (Volkow et al.,
2012). Thus, the clinical efficacy of stimulant drugs such asMPH
in ADHDmay depend, in part, on restoring D2/3 receptor signal-
ing in the ventral striatum of impulsive individuals.
In the present study, we therefore investigated the effects of
repeated oral administration of MPH on D2/3 receptor availabil-
ity in the ventral striatum of high-impulsive (HI) rats on the
five-choice serial reaction time task (5-CSRTT). Impulsivity in
this task is measured by the number of anticipatory responses to
an imminent visual signal and is analogous to false alarms on the
analogous continuous performance test in humans (Robbins,
2002). We used PET and the selective high-affinity D2/3 receptor
antagonist [18F]fallypride (Mukherjee et al., 1995) to investigate
D2/3 receptor availability in the ventral and dorsal striatum,
both before, and following chronic exposure of rats to MPH.
In parallel, we investigated the relationship between behav-
ioral impulsivity in selected low-impulsive (LI) versus HI rats
and MPH-evoked changes in D2/3 receptor availability in the
ventral and dorsal striatum.
Materials andMethods
Subjects. Ninety-six adult male Lister-hooded rats (Charles River),
weighing 250–275 g and 2–3 months of age at the beginning of behav-
ioral training, were used. Thesewere housed in groups of four in enclosed
ventilation chambers during the initial training and selection of HI and
LI rats. Upon completion of the screening and for the remaining period
of the study, rats were singly housed (n 8HI rats; n 7 LI rats), similar
to our previous study (Caprioli et al., 2013). Rats were singly housed
because MPH has been shown to disrupt social behavior in adolescent
and young adult rats (Beatty et al., 1982; Arakawa, 1994; Vanderschuren
et al., 2008). The holding roomwas humidity and temperature controlled
(22°C), and rats were maintained under a reversed 12 h light/dark cycle
(white lights off/red lights on at 7:00 A.M.). Food was restricted tomain-
tain bodyweights at 85–90%of free-feeding weights.Water was available
ad libitum. The present experiment conformed to the United Kingdom
Animals (Scientific Procedures) Act of 1986 and local ethical guidelines.
A timeline of experimental procedures is shown in Figure 1.
Five-choice serial reaction time task. The 5-CSRTT apparatus has been
described in detail previously (Bari et al., 2008). The training procedure
used in the present study was identical to that previously described (Cap-
rioli et al., 2013). In brief, rats were trained on the 5-CSRTT over 60
daily sessions (6 sessions per week) to detect the location of a brief visual
stimulus (0.7 s) presented on a random basis in one of the five recesses.
Each session consisted of 100 discrete trials and lasted30min. Training
was considered complete when rats responded to the target stimuli of
duration 0.7 s with an accuracy of 75% and omissions on20% of trials.
Trials were initiated by subjects entering the magazine. After a fixed
intertrial interval (ITI) of 5 s, a visual stimulus was presented in a single
aperture. Rats were rewarded with a single pellet if they correctly located
the position of the target stimulus (a “correct” response). A failure to
respond within a limited hold period of 5 s was deemed an “omission”
and was signaled by a 5 s time-out period and a loss of food reward on
that trial. Similar feedback was given on trials where rats responded in an
adjacent aperture (an “incorrect” response) or before the onset of the
light stimulus (a “premature” response). Behavioral performance
was assessed by the following: choice accuracy, (percentage correct re-
sponses/(correct incorrect trials); premature responding, (percentage
premature responses/(correct incorrect omission trials); omissions,
(percentage omission trials/(correct  incorrect  omission trials); la-
tency to collect food, (time from nose-poke response to entering the
magazine, in milliseconds); and correct response latency, (time to make
a response in the correct aperture after the onset of the light stimulus).
Once rats had acquired the 5-CSRTT, they were ranked for impulsivity
during a 3 week screening period. Each week consisted of 5 consecutive
days of testing with days 1, 2, 4, and 5 comprising sessions of 100 discrete
trials each and an ITI of 5 s [short ITI (S-ITI)]. During day 3, the ITI was
increased to 7 s to increase the frequency of premature responses [long
ITI (L-ITI)]. HI animals were defined as those exhibiting a level of pre-
mature responding of 50 on all three L-ITI sessions. LI rats were se-
lected from the remaining rats and responded prematurely on30% of
trials during the L-ITI sessions.
Long-term methylphenidate treatment. Methylphenidate hydrochlo-
ride (Sigma) was dissolved in Ribena (GlaxoSmithKline) and adminis-
tered orally (6 mg/ml/kg) twice a day (10:00 A.M. and 5:00 P.M.). The
oral route of administration was used to model the normal manner in
which this drug is administered clinically (Kuczenski and Segal, 2002;
Swanson and Volkow, 2009). Two days before the first oral dosing of
MPH, rats were trained to consume the Ribena solution from a 1 ml
syringe. Chronic MPH exposure was maintained for 7 d a week for 4
consecutive weeks (Fig. 1). During this period, rats were assessed for
performance on the 5-CSRTT at 8:00 A.M. when rats were in the drug-
free state (i.e., 15 h after the lastMPHadministration).During the last 7 d
of MPH treatment, rats were challenged with three L-ITI sessions, each
spaced 3 d apart.
Analysis of methylphenidate and ritalinic acid. Four nonimpulsive rats
were used to quantify plasma levels of MPH and its metabolite ritalinic
acid. Rats were orally administered Ribena spiked with 6mg/kgMPH, as
described above, and after 10 min were anesthetized with 5% isoflurane.
General anesthesia was maintained via the delivery of 1.5% isoflurane in
medical air. Blood samples were taken from a tail vein (0.5 ml) at 5, 15,
30, 60, 90, and 120 min following MPH administration. Blood was al-
lowed to clot at room temperature (24°C) before being centrifuged at
2000 rpm for 10 min. Plasma was aspirated from the centrifuged sample
and stored at80°C before the determination of MPH and ritalinic acid
using HPLC-tandem mass spectrometry (MS/MS). Calibration stan-
dards (range, 0.01–5 mg/L) were prepared with MPH and ritalinic acid
spiked in blank rat plasma. Quality control samples were similarly pre-
pared at 0.05, 1.00, and 1.50 mg/L. Calibration standards and triplicate
controls were carried through with each batch of analysis. Samples were
prepared by adding 50l of test specimen, calibrators, or controls to 2ml
of 100 mM phosphate buffer, pH 6.0, and spiking with the internal stan-
dard (10 l of 20% acetonitrile in 0.1% aqueous formic acid containing
100 pg trideuterated-MPH). The solutions were then placed in an ultra-
sonic bath for 10 min before extracting the drugs by adding to a precon-
ditioned Strata Screen-CGF 200mg/6ml solid phase extraction column.
Ritalinic acid was eluted first with hexane/ethyl acetate (50:50) followed
by MPH using dichloromethane/isopropanol/ammonia (78:20:2). The
eluates were evaporated to dryness at 30°C and reconstituted in 100l of
methanol/water before injection into anHPLC-MS/MS spectrometer for
analysis.HPLC separationwas achieved using a FORTIS 3mC18 150
3 mm column with detection using an API 3200 MS/MS system with a
TurboIon spray interface. The HPLC consisted of a Shimadzu system
withmobile phase A consisting of water containing 0.01% ammonia and
mobile phase B consisting of methanol containing 0.01% ammonia with
10 ml of isopropanol added per liter. The gradient run was 20–100%
mobile phase B over 10 min. Positive multiple reaction monitoring was
used tomonitor the chromatography column eluent [MPH (MRM234–
84), ritalinic acid (MRM 220–84) and d3-MPH (MRM 237–84)]. The
lower limit of detection was 0.008 mg/L (signal-to-noise ratio, 10) and
the lower limit of quantification was 0.01 mg/L. The overall precision
(between batch quality control specimens run on 4 separate days) was
2–11% within the calibration range used.
Positron emission tomography. HI and LI rats were scanned using
[18F]fallypride PET on the following two occasions: before the first oral
MPHdose and 2 d after the lastMPHdose, which occurredwithin 48 h of
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the last L-ITI session on the 5-CSRTT (Fig. 1). The scanning procedure
has been described in detail previously (Caprioli et al., 2013). In brief,
before the injection of tracer, single-mode transmission data were ac-
quired using a rotating 68Ge/ 68Ga point source (20 MBq) to provide
measured attenuation correction. For all scans, [18F]fallypride was in-
jected intravenously over 30 s, followed by a 15 s heparin-saline flush.
The injected [18F]fallypride activity (5.3–66.9MBq) was adjusted so that
the total mass of labeled and unlabeled fallypride injected was 0.5 nmol/
kg. Dynamic data were acquired in list mode for 180 min and subse-
quently binned into sinograms for the following time frames: 6  10 s,
3 20 s, 6 30 s, 10 60 s, 10 120 s, and 29 300 s. Corrections were
applied for randoms, dead time, normalization, attenuation, and decay.
Fourier rebinning (Defrise et al., 1997) was used to compress the four-
dimensional sinograms to three dimensions before reconstruction with
two-dimensional filtered back projection with a Hann window cutoff at
the Nyquist frequency. The image voxel size was 0.95 0.95 0.80mm,
with an array size of 128  128  95. The reconstructed images were
converted to kilobecquerels per milliliter using global and slice factors
determined from imaging a uniform phantom filled with a [18F]fluoride
solution.
Thirty-twoT2-weightedMRbrain scans fromprevious [18F]fallypride
PET studies in Lister-hooded rats were used to create a high-resolution
MR brain template with SyN (Avants et al., 2008), part of the Advanced
Normalization Tools (ANTS) package. A PET template was then created
by applying the spatial normalization parameters from the above tem-
plate creation process to late [18F]fallypride images (average image 120–
180 min after injection) that had been manually coregistered to their
corresponding MR scan. Late [18F]fallypride images from the 30 PET
scans in this study were affine registered to the PET template using
ANTS, and each transformation was used to reslice the corresponding
dynamic [18F]fallypride PET image set to template space. Finally, the
MR template used in a previous study (Caprioli et al., 2013; Fig. 2A)
was spatially normalized to the new MR template described above,
with the resulting transformation applied to the previously defined
regions of interest to align them to the new template space.
D2/3 receptor availability was quantified using nondisplaceable bind-
ing potential (BPND) (Innis et al., 2007), determined from reference
tissue-based kinetic analysis, with the cerebellum acting as the reference
region. The borders of the reference region drawn on the MR template
excluded the outermost lamina of the cerebellar cortex to avoid partial
volume error from uptake in the Purkinje cell layer. Regional and voxel-
wise BPND values were estimated from the distribution volume ratio
(DVR; BPND  DVR  1) determined using the reference tissue input
Logan plot (Logan et al., 1996) with data fitted from 90 to 180 min
postinjection.
Statistical analysis. Behavioral data were subjected to ANOVA (SPSS
version 17.0) using a general linear model. Homogeneity of variance was
verified using Levene’s test. For repeated-measures analyses, Mauchly’s
test of sphericity was applied, and the degrees of freedom were corrected
to more conservative values using the Huynh-Feldt  for any terms
involving factors in which the sphericity assumption was violated. Dif-
ferences in BPND between HI and LI rats were evaluated using repeated-
measures ANOVA. Significantly meaningful interactions (p 0.1) were
further analyzed by simple main effects using the pooled sum of square
error term (Cochran and Cox, 1957). A significance level of 0.05 was
used to interpret the main effects and post hoc tests. Pearson product
moment correlations were used to assess the strength of the association
between the following: (1) the change in BPND ((post-MPH  pre-
MPH)/(pre-MPH) 100) and baseline BPND (pre-MPH scan); and (2)
the change in premature responses ((post-MPH  pre-MPH)/(pre-
Figure 1. Effects of methylphenidate on sustained attention and impulsivity in selected LI versus HI rats. A, Timeline of the experimental procedure in rats expressing differential levels of
impulsive behavior on the5-CSRTT. Thedashed line refers to 5-CSRTT training,which took3months. Values shownareweeks.B, Effects of prior oralMPHadministrationon impulsivity in LI (white
bars) and HI (black bars) rats on the 5-CSRTT. Pre-cocaine administration values are averaged across 3 weekly spaced L-ITI sessions. It can be seen in B that impulsivity was altered both in HI and LI
rats (groupMPH interaction: F(1,13) 7.59, † p 0.05) during the challenge sessions. The increase in impulsivity post-MPHwas significant in LI rats (#p 0.044). C, Correlation plots showing
the relationship between relative changes in impulsivity frombaseline producedbyMPH. It canbe seen inC that the effect ofMPHon increasing impulsivitywas greatest in LI rats showing the lowest
baseline level of impulsivity (r0.80; p 0.03), whereasMPHdecreased impulsivity to a greater extent in those HI rats showing the highest baseline level of impulsivity (r0.7; p 0.05).
D, Differences in accuracy, omissions, and magazine latency before and after the oral MPH dosing between HI and LI rats (*p 0.05, **p 0.01, ***p 0.001 HI vs LI).
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MPH)  100) and baseline BPND (pre-MPH scan). All figures show
group means	 SEM.
Results
Segregation of high- and low-impulsivity groups
The behavioral performance of LI and HI rats on the 5-CSRTT
is summarized in Table 1. The percentages of premature re-
sponses for HI (n 8) and LI (n 7) rats, averaged across the
three L-ITI sessions before the commencement of MPH dos-
ing, were (mean 	 SEM) 69.6 	 7.5% and 21.5 	 2.2%, re-
spectively. HI rats were more impulsive than LI rats regardless
of the ITI being set to 5 s (baseline 1 to baseline 10; S-ITI; p
0.002) or 7 s (L-ITI; p 0.001). Among the various behavioral
variables recorded only attentional accuracy was significantly
impaired in HI rats compared with LI rats during the L-ITI
sessions (p  0.014). Although omissions appeared to be in-
creased in HI rats compared with LI rats, this contrast was not
significant (p  0.054).
Interactive effects of methylphenidate on impulsivity in LI
and HI rats
Twenty-one days after the commencement of daily MPH dosing,
rats were reassessed for impulsivity and attentional performance
on the 5-CSRTT. It can be seen in Figure 1B that MPH produced
divergent effects on impulsivity in the two impulsivity subgroups,
with impulsivity appearing to decrease in HI rats but increase in
LI rats (group  MPH interaction: F(1,13)  7.59, p  0.016).
Although post hoc t tests failed to reveal a significant decrease in
impulsivity, at a group level, followingMPH treatment in HI rats
(p  0.095), the increase in impulsivity observed in LI rats was
significant (p  0.044). Thus, following exposure to MPH, the
initial contrast in impulsivity between LI and HI rats was greatly
diminished. Importantly, it can be seen in Figure 1C that MPH
increased impulsivity in LI rats in an inverse relationship to the
baseline level of impulsivity, while impulsivity decreased in HI
rats, with the magnitude of the decrease being positively corre-
lated to the baseline level of impulsivity. Thus, the effect of MPH
on increasing impulsivity was greatest in LI rats showing the low-
est baseline level of impulsivity (r  0.80; p  0.03), whereas
MPH decreased impulsivity to a greater extent in those HI rats
showing the highest baseline level of impulsivity (r0.7; p
0.05). However, MPH did not restore the attentional inaccuracy
of HI rats, which remained significantly impaired relative to LI
rats (main effect of group: F(1,13)  3.62, p  0.049; group 
MPH interaction: F(1,13) 0.37, p 0.55). Moreover, there were
no significant effects ofMPH on omissions ormagazine latencies
on the 5-CSRTT (Fig. 1D; Table 1).
Modulation of D2/3 receptor availability in the ventral
striatum by MPH
Consistentwithour recent study (Caprioli et al., 2013), the availabil-
ityofD2/3 receptorswas significantly reduced in the left (t(13) 2.25,
p  0.043), but not the right (t(13)  1.29, p  0.219), ventral
striatum of drug-naive HI rats compared with LI rats (pre-/post-
Figure 2. MPH-induced effects on D2/3 receptor availability in the left ventral striatumof HI and LI rats.A, Three-dimensional depiction of regions of interest showing the ventral striatum (blue),
anterior dorsal striatum (green), and posterior dorsal striatum (red). B, Horizontal section through [18F]fallypride BPND maps for HI and LI rats overlaid on the coregistered MR template (L, left; R,
right). The images are 7 mm below the dorsal brain surface and have a BPND threshold 8. C, [
18F]fallypride BPND in the left and right ventral striatum of LI (circle symbols, n 7) and HI (square
symbols, n 8) rats before (pre-MPH) and after (post-MPH) oral administration. It can be seen that [18F]fallypride BPND is significantly reduced in the left ventral striatum of HI rats comparedwith
LI rats before MPH exposure (*p 0.05) and that MPH reduces the contrast in D2/3 receptor availability between LI and HI rats in the left ventral striatum.
Table 1. Summary of the effects of oral MPH administration on the behavioral
performance of LI and HI rats on the 5-CSRTT
Pre-MPH Post-MPH
LI (n 7) HI (n 8) LI (n 7) HI (n 8)
S-ITI sessions
Premature (%) 2.9	 0.5 8.6	 1.2* 2.7	 0.6 4.4	 0.7
Accuracy (%) 83.0	 1.7 80.4	 1.7 83.4	 1.0 79.8	 2.0
Omissions (%) 12.5	 2.2 9.0	 1.4 7.5	 1.1 6.7	 1.2
Magazine latency
(ms)
1169.4	 91.9 1156.4	 58.4 1213.8	 85.5 1159.5	 51.2
Correct latency
(ms)
751.6	 38.0 626.0	 41.8 842.4	 50.9 688.1	 40.0
L-ITI sessions
Premature (%) 21.5	 2.2 69.6	 7.5** 32.1	 2.9 53.3	 4.6*
Accuracy (%) 80.9	 1.0 73.9	 2.1*** 80.5	 1.7 74.9	 1.9***
Omissions (%) 12.7	 1.9 18.7	 2.6 8.6	 1.7 11.3	 2.0
Magazine latency
(ms)
1103.9	 54.0 1281.9	 122.7 1186.6	 96.7 1140.1	 49.0
Correct latency
(ms)
671.7	 38.6 601.6	 32.5 721.8	 63.2 603.0	 26.0
Data are reported as the mean	 SEM. *p 0.01; **p 0.001; ***p 0.05 (LI vs HI).
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MPHhemisphere group interaction:F(1,13) 5.75, p 0.05;
group hemisphere interaction: F(1,13) 4.047, p 0.066; Fig.
2C). Following 28 d of exposure to MPH, the difference in D2/3
receptor availability between LI and HI rats in the left ventral
striatum was no longer evident (t(13)  0.09, p  0.930). The
normalizing effect ofMPHonD2/3 receptor availability in the left
ventral striatum appeared to be explained by a near-significant
reduction in D2/3 BPND in the LI rats (t(6) 2.292, p 0.062)
rather than an increase in D2/3 BPND in this region of HI rats
(t(7)0.495, p 0.636). Exposure of LI and HI rats to MPH
had no significant effect on D2/3 receptor availability in the
right ventral striatum.
Baseline-dependent effects of MPH on striatal D2/3 receptors
in HI rats
We found no significant group differences in D2/3 receptor avail-
ability between LI and HI rats in the dorsal striatum, either at
baseline (pre-MPH) or following MPH treatment (data not
shown). However, when we compared the change in [18F]fally-
pride BPND before and after drug administration, we found that
MPH both increased and decreased [18F]fallypride BPND in the
ventral and dorsal striatum in HI rats, depending on the baseline
availability of D2/3 receptors (Fig. 3). In the ventral striatum,
we observed a strong inverse relationship between the percentage
change in [18F]fallypride BPND and baseline [
18F]fallypride BPND
in both the left hemisphere (rleft  0.73, p  0.01) and right
hemisphere (rright0.58, p 0.01). Baseline-dependent effects
of MPH on D2/3 receptor availability were also observed in the
anterior and posterior dorsal striata of HI rats. For all regions of
interest, the relationshipwas strongly inversely related to baseline
D2/3 receptor availability (anterior dorsal striatumHI rats: rleft
0.74,0.01; rright0.64, p 0.01; posterior dorsal striatum
HI rats: rleft  0.61, p  0.01, rright  0.72, p  0.01). In
contrast, we did not observe baseline-dependent effects on
D2/3 receptor availability in any of the striatal areas investi-
gated in LI rats.
We next compared the relative changes in D2/3 receptor avail-
ability and impulsivity produced byMPH treatment (Fig. 4). We
found no significant relationship between these parameters in
any of the striatal subregions examined for either LI or HI rats.
Discussion
This study investigated striatal D2/3 receptor availability in highly
impulsive rats and the mechanisms underlying the therapeutic
effects of long-termoralMPH treatment.We found that repeated
oral MPH administration was sufficient to produce bidirectional
effects on impulsivity that depended on the baseline level of im-
pulsivity. Thus, in LI rats,MPH increased impulsivity, whereas in
HI rats it reduced impulsivity in animals exhibiting the highest
baseline level of impulsivity, consistent with an underlying rate-
dependent mechanism. Our results indicate that the rate depen-
dency model held for LI and HI rats but with clear differences in
the underlying regulatory parameters, which is suggestive of a
nonunitary process. Since the baseline-dependent effects ofMPH
on impulsivity and D2/3 receptors were dissociable, we conclude
that D2/3 receptors may not play a major contribution to the
Figure 3. A,B, Relationship between the percentage change in [18F]fallypride BPND in the ventral and dorsal striatum before and after the exposure of LI (A) and HI (B) rats to MPH as a function
of baseline (i.e., pre-MPH) [18F]fallypride BPND. The results show that the effects of MPH on D2/3 receptor availability depend inversely on baseline [
18F]fallypride BPND values in the anterior and
posterior regions of the dorsal striatum, as well as in the ventral striatum of HI but not LI rats. The horizontal dotted line depicts no net effect of MPH on [18F]fallypride BPND values. Pearson product
moment correlation coefficients and p values are given in each panel.
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effects of MPH on impulsivity. These data are consistent with
findings showing that MPH modulates performance in humans
in a baseline-dependent manner both in healthy controls and in
subjects in whom ADHD has been diagnosed (del Campo et al.,
2013).
We found a strong inverse relationship between baseline D2/3
BPND and the change in this parameter after MPH treatment in
HI rats. However, no such relationship was found for LI rats in
any of the striatal subregions examined. These findings corre-
spondwith our earlier findings in rats self-administering cocaine,
which had the similar effect ofmodulatingD2/3 BPND in amanner
dependent on baseline D2/3 BPND values (Caprioli et al., 2013).
However, in our previous study, cocaine also modulated D2/3
receptors in the dorsal striatum. The more pervasive effects of
cocaine on D2/3 receptors throughout the ventral and dorsal stri-
ata may be due to differences in the route of administration (in-
travenous vs oral), response-contingent cocaine vs response
noncontingent MPH, differing quantities of cocaine and MPH,
and higher relative efficacy of cocaine over MPH. This may ex-
plain why cocaine produced a more substantial reduction in im-
pulsivity in the HI subgroup compared with MPH in the present
study (Caprioli et al., 2013).
The mechanism underlying the observed rate-dependent
modulation of impulsivity followingMPH treatment is unknown
but, as discussed above, may be distinct for LI and HI rats. Al-
though for LI rats there was no obvious relationship between
baseline D2/3 BPND and the change in this parameter following
MPH treatment, at a group level, MPH had the trend effect of
reducing D2/3 BPND values in the left ventral striatum, a deficit
associated with increased impulsivity on this task (Dalley et al.,
2007) and localized to the nucleus accumbens shell (Besson et al.,
2010; Jupp et al., 2013). The reduction in D2/3 receptor availabil-
ity in LI rats may reflect a downregulation of D2/3 receptors, but
since [18F]fallypride competes with DA in binding to D2/3 recep-
tors, it could also reflect an increase in synaptic DA release, pos-
sibly due to sensitization of themesolimbicDA systems following
repeated MPH treatment (Shuster et al., 1982; Gaytan et al.,
1997). However, sensitization of the locomotion response does
not appear to develop after long-term oral MPH treatment (Mc-
Namara et al., 1993; Kuczenski and Segal, 2002). Furthermore, no
simple relationship exists between hyperactivity and impulsivity
on the 5-CSRTT (Dalley et al., 2007; Molander et al., 2011;
Moreno et al., 2013).
In HI rats, MPH had the dual effect of decreasing impulsivity
and modulating striatal D2/3 receptor availability according to
the principal of rate dependency (Dews and Wenger, 1977).
However, neither parameter significantly covaried after MPH
Figure 4. A,B, Correlation plots showing the relationship between relative changes in impulsivity and [18F]fallypride BPND in the ventral and dorsal striatum of LI (A) and HI (B) rats produced by
MPH. The results indicate that the effects of MPH on impulsivity and D2/3 receptor availability are independent. The vertical dotted line depicts no net effect of MPH on [
18F]fallypride BPND. Pearson
product moment correlation coefficients and p values are given in each panel.
Table 2. Summary of the serum concentration of oral MPH and ritalinic acid
obtained from four nonimpulsive rats after a single oral dose of MPH (6mg/kg)
Collection time





MPH RA MPH RA MPH RA MPH RA
5 min 112.5 107.5 20.6 42.7 90.0 60.0 130.0 160.0
15 min 102.5 142.5 22.2 20.6 90.0 120.0 130.0 170.0
30 min 87.5 145.0 22.2 20.8 70.0 120.0 120.0 170.0
60 min 9.5 67.5 7.50 15.0 4.0 50.0 20.0 80.0
90 min 2.2 35.0 0.91 5.78 1.0 30.0 3.0 40.0
120 min 1.0 13.0 0.11 8.71 1.0 2.0 1.0 20.0
RA, Ritalinic acid.
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treatment, suggesting that the modifying effects of MPH on im-
pulsivity are separable from effects on D2/3 receptor regulation.
That the measure of impulsivity is not directly related to changes
in D2/3 receptor availability is possibly due to other actions of
MPH, especially for example on NE. Thus, atomoxetine, which
reduces impulsivity in HI rats, blocks reuptake of NE and has no
effect on subcortical DA (Bymaster et al., 2002). Moreover, this
drug exerts at least some of its anti-impulsive effects within the
shell region of the nucleus accumbens (Economidou et al., 2012).
Alternatively, the reduction in impulsivity in MPH-treated HI
rats may include actions at the level of the nucleus accumbens
core. Thus, previously, we have shown that HI rats exhibit a
reduced density of markers associated with dendritic spines in
this region andGABA synthesis (Caprioli et al., 2014), abnormal-
ities that were mainly restricted to the left hemisphere, similar to
the locus of deficientD2/3 receptor availability inHI rats (Caprioli
et al., 2013). Since in the present study MPH had the greatest
beneficial effects in themost impulsive animals, these effects may
be mediated by a restoration of the structural and functional
integrity of GABAergic medium spiny neurons in the nucleus
accumbens core, as previously hypothesized (Caprioli et al.,
2014). The origin of the hemispheric imbalance in D2/3 receptors
in HI rats is unknown but may arise from genetic and/or envi-
ronmental factors affecting trophic signaling during develop-
ment (Concha et al., 2012). Left/right asymmetries in the
midbrain DA systems have been reported in rats (Carlson and
Glick, 1989; Afonso et al., 1993; Rodriguez et al., 1994) and
healthy humans (Tomer et al., 2008), aswell as in individualswith
ADHD (Volkow et al., 2007a, 2009; del Campo et al., 2013).
An analogous PET study in rats found that treating rats with
oral MPH for 8 months, initiated during the periadolescent pe-
riod, increased D2/3 availability in the striatum (Thanos et al.,
2007). By contrast, striatal D2/3 availability decreased 2 months
after starting MPH treatment. These findings demonstrate that
the MPH-induced changes in striatal D2/3 receptors depend on
treatment length and developmental stage (Rodriguez et al.,
2010;Gill et al., 2012). Themechanisms underlying these changes
in D2/3 receptors are unknown but may involve alterations in
synaptic DA and/or the pool of receptors available for binding in
the striatum. However, research in nonhuman primates demon-
strates that long-term treatment with extended-release MPH for
1 year has no effect on the DA transporter or D2/3 receptors in the
striatum (Soto et al., 2012; Gill et al., 2012). This discrepancywith
rodent studies may be species specific or a consequence of differ-
ing doses of MPH and/or length of treatment. In the context of
the present study, it may also reflect the fact that animals in the
study by Gill et al., 2012 were not preselected for impulsivity-
related traits. This may be relevant, as it has been shown that
treating adults with ADHD for 1 year decreases striatal D2/3 re-
ceptor availability, as assessed using PET (Volkow et al., 2012).
There are several limitations of the present study that merit
discussion. First, although we dosedMPH orally and assessed the
levels of serumMPHand itsmetabolite ritalinic acid, as endorsed
by others (Volkow and Insel, 2003; Gill et al., 2012), peak MPH
levels were in excess of the typical therapeutic range of MPH of
8–10 ng/ml (Swanson and Volkow, 2002; Table 2). However,
consistent with other research (Patrick et al., 1984; Robb et al.,
2014), MPH was rapidly cleared with an elimination half-life of
30–50 min. Thus, although serum levels of MPH were initially
high, these soon declined to clinically relevant values after the
administration of MPH and well before the next dose. Neverthe-
less, with twice-daily dosing and consequent fluctuations in se-
rumMPH levels, our results are difficult to extrapolate to studies
in humans that use extended-release oral formulations (Robb et
al., 2014). A second consideration is that the primary objective of
our research was to investigate the long-term effects of MPH on
impulse control and D2/3 receptors in the striatum. The design of
our study thus excluded the analysis of short-term treatmentwith
low doses of MPH, which increase NE and DA availability selec-
tively in the prefrontal cortex (Berridge et al., 2006) and facilitate
cognitive functions relevant to ADHD (Andrzejewski et al.,
2014). Third, our conclusions are based on relatively small group
sizes (n  7–8). Nevertheless, we have now reported in three
independent studies reduced striatal D2/3 receptor availability in
the ventral striatum of HI rats. In addition, we observed qualita-
tively similar changes from baseline following the administration
of MPH and cocaine (Caprioli et al., 2013), using a within-
subjects longitudinal design.
In conclusion, our results confirm that deficits in impulsive
control are associated with reduced D2/3 receptor availability in
the left ventral striatum, as previously reported (Dalley et al.,
2007; Caprioli et al., 2013), and in three independent studies in
ADHD patients (Volkow et al., 2007a, 2009; del Campo et al.,
2013). Although further research is needed to test the full dose–
responsecurveofMPHonimpulsivity andD2/3 receptoravailability,
we have now shown how different psychomotor stimulant drugs
produce baseline-dependent effects on D2/3 receptor availability in
the ventral striatum. In addition, we have demonstrated that the
therapeutic effects of MPH on impulsivity are unlikely to arise as
a direct consequence of changes in the regulation of D2/3 recep-
tors in the ventral striatum, a conclusion supported by research in
adults with ADHD (Volkow et al., 2012). Nevertheless, by restor-
ing levels ofD2/3 receptors in the ventral striatumofHI rats,MPH
may diminish the risk of addiction in addiction-prone highly
impulsive rats (Belin et al., 2008; Economidou et al., 2009).
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